BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4529323)

  • 21. Cell-mediated suppression of tumor immunity has a non-specific component. II. Evidence from cell culture experiments.
    Hellström I; Hellström KE
    Int J Cancer; 1981; 27(4):487-91. PubMed ID: 6168592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of anti-embryo immunization on methylcholanthrene-induced sarcoma growth in BALB/c mice.
    Parmiani G; Lembo R
    Int J Cancer; 1974 Oct; 14(4):555-64. PubMed ID: 4617712
    [No Abstract]   [Full Text] [Related]  

  • 24. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract]   [Full Text] [Related]  

  • 25. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW; Skurzak HM; Klein E
    Int J Cancer; 1972 Nov; 10(3):581-8. PubMed ID: 4128689
    [No Abstract]   [Full Text] [Related]  

  • 26. Decrease of cytotoxic immune lymphoid cells following regression of virus-induced sarcomas in mice.
    Levy JP; Lechlerc JC; Gomard E; Pavie J; Kourilsky F
    Bibl Haematol; 1973; 39():689-97. PubMed ID: 4798253
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.
    Hellström I; Hellström KE
    Int J Cancer; 1969 Sep; 4(5):587-600. PubMed ID: 5349009
    [No Abstract]   [Full Text] [Related]  

  • 28. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
    Lilley DP; Burger DR; Vetto RM
    J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
    [No Abstract]   [Full Text] [Related]  

  • 34. The age related responses of New Zealand mice to a murine sarcoma virus.
    Gazdar AF; Beitzel W; Talal N
    Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-chemical carcinogenesis: a possible viral immunologic influence on 3-methylcholanthrene sarcoma induction.
    Whitmire CE
    J Natl Cancer Inst; 1973 Aug; 51(2):473-8. PubMed ID: 4358133
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
    Crowe NY; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-induced redistribution of normal and tumor associated surface antigens.
    Yefenof E; Klein G
    Exp Cell Res; 1974 Oct; 88(2):217-24. PubMed ID: 4372068
    [No Abstract]   [Full Text] [Related]  

  • 40. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
    Pilch YH
    Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.